What Is Digipharm(DPH)? Complete Guide Review About Digipharm.


What Is Digipharm(DPH)?

Digipharm solutions aim to accelerate the much needed restructuring of healthcare delivery systems to a value-based approach. The inherent flaws of current global healthcare infrastructure result in substantial inefficiency, wastage and sub-optimal health outcomes for the most important stakeholder; the patient. In healthcare today, there is a lack of incentive for health systems and providers to focus on mutually beneficial collaboration and the maximization of patient outcomes.

Digipharm utilises blockchain technology to overcome key infrastructural limitations to innovative pricing and evidence generation. DIGIPHARMs’ platforms drive value improvement, reward innovation and expedite the transformation to value-based, personalized healthcare. This results in patients who are most at need being denied or delayed access to novel treatments like cutting edge pharmacological therapies, an opportunity missed to decrease the long term economic and disease burden on health systems, and a barrier to reimbursement for manufacturers and healthcare providers.

Digipharm Storage Key Points

Coin BasicInformation
Coin NameDigipharm
Short NameDPH
Circulating Supply7,581,100.00 DPH
Total Supply1,000,000
Source CodeClick Here To View Source Code
ExplorersClick Here To View Explorers
Twitter PageClick Here To Visit Twitter Group
WhitepaperClick Here To View
Official Project WebsiteClick Here To Visit Project Website

Barriers to Innovative pricing and ‘paying for performance’

Digipharm Healthcare systems are often required to make the difficult decision of whether to reimburse costly therapies and provide access for patients while taking into account their limited resources. Innovative pricing approaches and ‘value-based’ healthcare have the ability to overcome the challenges faced by healthcare systems when funding treatment, enabling the implementation of ‘flexible’ pricing schemes to determine the cost of treatment in relation to the benefits and ‘true value’ it delivers.

Unfortunately, healthcare systems around the world lack the relevant infrastructure to efficiently track and implement innovative pricing models such as value-based pricing agreements, and so are reluctant to adopt such innovative policies. Digipharm Additionally, patients do not have access to relevant RWE that enables them to explore health outcomes and valuable health information in accordance to their personal characteristics.

Limitations of conventional real world evidence

Digipharm Real world evidence (RWE) is playing an increasingly influential role in informing decision making within the healthcare industry and is crucial to informing value-based healthcare. Yet the delay of RWE outputs, the expenses of data access and the current methods of data collection negate many of the benefits of utilizing these rich data resources. The lack of easily accessible and comprehensive RWE currently prevents stakeholders in healthcare to evaluate the real time performance and value provided by therapy in real life clinical practice as part of a value-based healthcare system.

Innovative pricing and Value-Based Healthcare (VBHC)

The digitization of healthcare is a key element to improving patient outcomes, their quality of life and reducing the intense burden on health systems worldwide. Digipharm The healthcare industry is experiencing a paradigm shift to value-based care due to growth in demand, aging populations, chronic diseases and unsustainable levels of health related expenditure.

Health systems are transitioning toward value-based care to prevent the rationing of services and increased costs for patients and payers without compromising quality of care. Provision of healthcare from a value-based perspective is based on the underlying aim of generating optimal patient outcomes relative to the monetary spend.

Data security & privacy

Utilising blockchain technology for Digipharm platforms promotes the development of a decentralized health information infrastructure that is ubiquitous, transparent and security conscious. In May 2017, The National Health Service (NHS) in the UK was subject to one of the largest ransomware attacks in history, crippling almost 50 NHS trusts, leaving confidential data at risk and the halt of numerous services which only added to the misfortune of patients.